Michele Cilli
Michele Cilli
Ospedale Policlinico San Martino - Genova - IT
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy
F Pastorino, C Brignole, D Marimpietri, M Cilli, C Gambini, D Ribatti, ...
Cancer research 63 (21), 7400-7409, 2003
TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
P Valente, G Fassina, A Melchiori, L Masiello, M Cilli, A Vacca, M Onisto, ...
International journal of cancer 75 (2), 246-253, 1998
Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy
F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ...
Cancer research 66 (20), 10073-10082, 2006
The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice
B Bachmeier, A Nerlich, C Iancu, M Cilli, E Schleicher, R Vené, R Dell'Eva, ...
Cellular physiology and biochemistry 19 (1-4), 137-152, 2007
Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome
C Lunardi, C Bason, M Leandri, R Navone, M Lestani, E Millo, U Benatti, ...
The Lancet 360 (9337), 915-921, 2002
Fasting-mimicking diet and hormone therapy induce breast cancer regression
I Caffa, V Spagnolo, C Vernieri, F Valdemarin, P Becherini, M Wei, ...
Nature 583 (7817), 620-624, 2020
Clonal analysis of stably transduced human epidermal stem cells in culture.
MB Mathor, G Ferrari, E Dellambra, M Cilli, F Mavilio, R Cancedda, ...
Proceedings of the National Academy of Sciences 93 (19), 10371-10376, 1996
p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily
C Cantoni, S Verdiani, M Falco, A Pessino, M Cilli, R Conte, D Pende, ...
European journal of immunology 28 (6), 1980-1990, 1998
Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis
C Brignole, D Marimpietri, F Pastorino, B Nico, D Di Paolo, M Cioni, ...
Journal of the National Cancer Institute 98 (16), 1142-1157, 2006
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
C Marini, B Salani, M Massollo, A Amaro, AI Esposito, A Maria Orengo, ...
Cell cycle 12 (22), 3490-3499, 2013
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy
I Airoldi, E Di Carlo, C Cocco, C Sorrentino, F Fais, M Cilli, T D'Antuono, ...
Blood 106 (12), 3846-3853, 2005
Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model
T Mirabella, M Cilli, S Carlone, R Cancedda, C Gentili
Biomaterials 32 (15), 3689-3699, 2011
Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS)
S Tavella, A Ruggiu, A Giuliani, F Brun, B Canciani, A Manescu, ...
PLoS one 7 (3), e33179, 2012
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
F Pastorino, D Di Paolo, F Piccardi, B Nico, D Ribatti, A Daga, G Baio, ...
Clinical Cancer Research 14 (22), 7320-7329, 2008
Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor
MM Santoro, L Penengo, M Minetto, S Orecchia, M Cilli, G Gaudino
Oncogene 17 (6), 741-749, 1998
Retracted: Role of α7‐nicotinic acetylcholine receptor in human non‐small cell lung cancer proliferation
L Paleari, A Catassi, M Ciarlo, Z Cavalieri, C Bruzzo, D Servent, A Cesario, ...
Cell proliferation 41 (6), 936-959, 2008
Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene
M Giampuzzi, G Botti, M Cilli, R Gusmano, A Borel, P Sommer, ...
Journal of Biological Chemistry 276 (31), 29226-29232, 2001
Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies
E Gazzerro, S Assereto, A Bonetto, F Sotgia, S Scarfì, A Pistorio, ...
The American journal of pathology 176 (4), 1863-1877, 2010
Natural agents targeting the α7‐nicotinic‐receptor in NSCLC: A promising prospective in anti‐cancer drug development
A Grozio, L Paleari, A Catassi, D Servent, M Cilli, F Piccardi, M Paganuzzi, ...
International journal of cancer 122 (8), 1911-1915, 2008
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
M Loi, S Marchiò, P Becherini, D Di Paolo, M Soster, F Curnis, C Brignole, ...
Journal of controlled release 145 (1), 66-73, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20